Rationale and design of the Cyclosporine to ImpRove Clinical oUtcome in ST-elevation myocardial infarction patients (the CIRCUS trial)

American Heart Journal

Volumn 169, Issue 6, 2015, Pages 758-766.e6

  Mewton, Nathan ^a   Cung, Thien T ^b   Morel, Olivier ^c   Cayla, Guillaume ^d   Bonnefoy Cudraz, Eric ^e   Rioufol, Gilles ^e   Angoulvant, Denis ^f   Guerin, Patrice ^g   Elbaz, Meyer ^h   Delarche, Nicolas ⁱ   Coste, Pierre ^j   Vanzetto, Gerald ^k   Metge, Marc ^l   Aupetit, Jean François ^m   Jouve, Bernard ⁿ   Motreff, Pascal ^o   Tron, Christophe ^p   Labeque, Jean Noël ^q   Steg, Pierre G ^r   Cottin, Yves ^s   Range, Grégoire ^t   Clerc, Jerome ^u   Coussement, Patrick ^v   Prunier, Fabrice ^w   Moulin, Frederique ^x   Roth, Olivier ^y   Belle, Loic ^z   Dubois, Phillipe ^aa   Barragan, Paul ^ab   Gilard, Martine ^ac   Piot, Christophe ^ad   Colin, Patrice ^ae   Morice, Marie Claude ^af   Monassier, Jean Pierre ^ag   Ider, Omar ^ag   Dubois Randé, Jean Luc P ^ah   Unterseeh, Thierry ^ai   Lebreton, Hervé ^aj   Beard, Thierry ^ak   Blanchard, Didier ^al   Grollier, Gilles ^am   Malquarti, Vincent ^an   Staat, Patrick ^ao   Sudre, Arnaud ^ap   Hansson, Magnus J ^aq   Elmer, Eskil ^aq   Boussaha, Inesse ^a   Jossan, Claire ^a   Torner, Anna ^ar   Claeys, Marc ^as   Garcia Dorado, David ^at   Ovize, Michel ^a   more..

^a HOSPICES CIVILS DE LYON   (France)

^b HÔPITAL ARNAUD DE VILLENEUVE   (France)

^c UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^d NÎMES UNIVERSITY HOSPITAL   (France)

^e LOUIS PRADEL HOSPITAL   (France)

^f UNIVERSITY HOSPITAL OF TOURS   (France)

^g CHU de Nantes   (France)

^h CHU RANGUEIL   (France)

ⁱ CENTRE HOSPITALIER DE PAU   (France)

^j HAUT LÉVÊQUE HOSPITAL   (France)

^k HÔPITAL MICHALLON   (France)

^l Hôpital Henri Duffau   (France)

^m CENTRE HOSPITALIER SAINT JOSEPH SAINT LUC   (France)

ⁿ CENTRE HOSPITALIER DU PAYS D AIX   (France)

^o SERVICE DE RHUMATOLOGIE   (France)

^p HÔPITAL CHARLES NICOLLE   (France)

^q Clinique de la Fourcade   (France)

^r BICHAT HOSPITAL   (France)

^s HÔPITAL DU BOCAGE   (France)

^t Centre Hospitalier General   (France)

^u Centre Hospitalier Compiegne   (France)

^v General Hospital St Jan   (Belgium)

^w ANGERS UNIVERSITY HOSPITAL   (France)

^x CHU NANCY BRABOIS   (France)

^y CENTRE HOSPITALIER DE MULHOUSE   (France)

^z Centre Hospitalier de la Region d'Annecy   (France)

^aa HENRI MONDOR HOSPITAL   (France)

^ab Polyclinique les Fleurs   (France)

^ac SERVICE DE RHUMATOLOGIE   (France)

^ad Clinique Du Millenaire   (France)

^ae Clinique Esquirol   (France)

^af Institut Jacques Cartier   (France)

^ag Clinique du sport   (France)

^ah Centre Hospitalier Universitaire de Charleroi   (Belgium)

^ai Hôpital Claude Galien   (France)

^aj PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

^ak Clinique de l'Ormeau   (France)

^al Clinique Saint Gatien   (France)

^am CHU CÔTE DE NACRE   (France)

^an Clinique de la Sauvegarde   (France)

^ao Clinique du Tonkin   (France)

^ap LILLE UNIVERSITY HOSPITAL   (France)

^aq LUND UNIVERSITY   (Sweden)

^ar Scandinavian Development Services   (Sweden)

^as ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^at HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CREATINE KINASE; CYCLOSPORIN; PLACEBO; TROPONIN I; TROPONIN T;

ANGIOCARDIOGRAPHY; ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG INFUSION; ELECTROCARDIOGRAM; HEART FAILURE; HEART INFARCTION SIZE; HEART MUSCLE PERFUSION; HEART MUSCLE REPERFUSION; HEART MUSCLE REVASCULARIZATION; HEART VENTRICLE REMODELING; HUMAN; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MAJOR CLINICAL STUDY; MULTICENTER STUDY; OUTCOMES RESEARCH; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; REPERFUSION INJURY; SINGLE DRUG DOSE; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; TRANSLUMINAL CORONARY ANGIOPLASTY; TRANSTHORACIC ECHOCARDIOGRAPHY; TREATMENT OUTCOME; BLOOD; CLINICAL TRIAL; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; MALE; MYOCARDIAL INFARCTION; PATHOPHYSIOLOGY; TIME;

BIOLOGICAL MARKERS; CORONARY ANGIOGRAPHY; CYCLOSPORINE; DOUBLE-BLIND METHOD; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; MALE; MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; PROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 84930147019     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2015.02.020     Document Type: Article

References (41)

1. R.J. Gibbons, U.S. Valeti, and P.A. Araoz The quantification of infarct size J Am Coll Cardiol 44 8 2004 1533 1542
2. J. Lonborg, N. Vejlstrup, and H. Kelbaek Final infarct size measured by cardiovascular magnetic resonance in patients with ST elevation myocardial infarction predicts long-term clinical outcome: an observational study Eur Heart J Cardiovasc Imaging 14 4 2013 387 395
3. P.G. Steg, S.K. James, and D. Atar ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC) Eur Heart J 33 20 2012 2569 2619
4. E. Puymirat, T. Simon, and P.G. Steg Association of changes in clinical characteristics and management with improvement in survival among patients with ST-elevation myocardial infarction JAMA 308 10 2012 998 1006
5. T. Reffelmann, and R.A. Kloner The no-reflow phenomenon: A basic mechanism of myocardial ischemia and reperfusion Basic Res Cardiol 101 5 2006 359 372
6. S.H. Rezkalla, and R.A. Kloner No-reflow phenomenon Circulation 105 5 2002 656 662
7. D.M. Yellon, and D.J. Hausenloy Myocardial reperfusion injury N Engl J Med 357 11 2007 1121 1135
8. C.P. Baines, R.A. Kaiser, and N.H. Purcell Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death Nature 434 7033 2005 658 662
9. F. Di Lisa, R. Menabo, and M. Canton Opening of the mitochondrial permeability transition pore causes depletion of mitochondrial and cytosolic NAD+ and is a causative event in the death of myocytes in postischemic reperfusion of the heart J Biol Chem 276 4 2001 2571 2575
10. E.J. Griffiths, and A.P. Halestrap Mitochondrial non-specific pores remain closed during cardiac ischaemia, but open upon reperfusion Biochem J 307 Pt 1 1995 93 98
11. A.W. Leung, and A.P. Halestrap Recent progress in elucidating the molecular mechanism of the mitochondrial permeability transition pore Biochim Biophys Acta 1777 7-8 2008 946 952
12. S. Javadov, and M. Karmazyn Mitochondrial permeability transition pore opening as an endpoint to initiate cell death and as a putative target for cardioprotection Cell Physiol Biochem 20 1-4 2007 1 22
13. M. Crompton The mitochondrial permeability transition pore and its role in cell death Biochem J 341 Pt 2 1999 233 249
14. S. Morota, T. Manolopoulos, and A. Eyjolfsson Functional and pharmacological characteristics of permeability transition in isolated human heart mitochondria PLoS One 8 6 2013 e67747
15. M.R. Duchen, O. McGuinness, and L.A. Brown On the involvement of a cyclosporin A sensitive mitochondrial pore in myocardial reperfusion injury Cardiovasc Res 27 10 1993 1790 1794
16. L. Argaud, L. Gomez, and O. Gateau-Roesch Trimetazidine inhibits mitochondrial permeability transition pore opening and prevents lethal ischemia-reperfusion injury J Mol Cell Cardiol 39 6 2005 893 899
17. A. Skyschally, R. Schulz, and G. Heusch Cyclosporine A at reperfusion reduces infarct size in pigs Cardiovasc Drugs Ther 24 1 2010 85 87
18. P. Chiari, D. Angoulvant, and N. Mewton Cyclosporine protects the heart during aortic valve surgery Anesthesiology 121 2 2014 232 238
19. C. Piot, P. Croisille, and P. Staat Effect of cyclosporine on reperfusion injury in acute myocardial infarction N Engl J Med 359 5 2008 473 481
20. C. Savoye, O. Equine, and O. Tricot Left ventricular remodelling after anterior wall acute myocardial infarction in modern clinical practice (from the REmodelage VEntriculaire [REVE] study group) Am J Cardiol 98 9 2006 1144 1149
21. K.H. Ehinger, M.J. Hansson, and F. Sjovall Bioequivalence and tolerability assessment of a novel intravenous ciclosporin lipid emulsion compared to branded ciclosporin in Cremophor (R) EL Clin Drug Investig 33 1 2013 25 34
22. J.T. Ortiz-Perez, S.N. Meyers, and D.C. Lee Angiographic estimates of myocardium at risk during acute myocardial infarction: validation study using cardiac magnetic resonance imaging Eur Heart J 28 14 2007 1750 1758
23. P.S. Douglas, M.J. Garcia, and D.E. Haines ACCF/ASE/AHA/ASNC/HFSA/HRS/SCAI/SCCM/SCCT/SCMR 2011 Appropriate Use Criteria for Echocardiography. A Report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, American Society of Echocardiography, American Heart Association, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, Society of Critical Care Medicine, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance American College of Chest Physicians J Am Soc Echocardiogr 24 3 2011 229 267
24. M.H. Picard, D. Adams, and S.M. Bierig American Society of Echocardiography recommendations for quality echocardiography laboratory operations J Am Soc Echocardiogr 24 1 2011 1 10
25. J. Lonborg, L. Holmvang, and H. Kelbaek ST-Segment resolution and clinical outcome with ischemic postconditioning and comparison to magnetic resonance Am Heart J 160 6 2010 1085 1091
26. G.W. Stone, A. Maehara, and B. Witzenbichler Intracoronary abciximab and aspiration thrombectomy in patients with large anterior myocardial infarction: the INFUSE-AMI randomized trial JAMA 307 17 2012 1817 1826
27. K. Thygesen, J.S. Alpert, and A.S. Jaffe Third universal definition of myocardial infarction Eur Heart J 33 20 2012 2551 2567
28. N. Mewton, H. Thibault, and F. Roubille Postconditioning attenuates no-reflow in STEMI patients Basic Res Cardiol 108 6 2013 383 388 10.1007/s00395-013-0383-8
29. F. Thuny, O. Lairez, and F. Roubille Post-conditioning reduces infarct size and edema in patients with ST-segment elevation myocardial infarction J Am Coll Cardiol 59 24 2012 2175 2181
30. L. Bolognese, A.N. Neskovic, and G. Parodi Left ventricular remodelling after primary coronary angioplasty: patterns of left ventricular dilation and long-term prognostic implications Circulation 106 18 2002 2351 2357
31. R.L. Prentice Surrogate endpoints in clinical trials: definition and operational criteria Stat Med 8 4 1989 431 440
32. P. Staat, G. Rioufol, and C. Piot Postconditioning the human heart Circulation 112 14 2005 2143 2148
33. Z.Q. Zhao, J.S. Corvera, and M.E. Halkos Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning Am J Physiol Heart Circ Physiol 285 2 2003 H579 H588
34. M. Ovize, G.F. Baxter, and F. Di Lisa Postconditioning and protection from reperfusion injury: where do we stand? Position paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology Cardiovasc Res 87 3 2010 406 423
35. J. Lonborg, H. Kelbaek, and N. Vejlstrup Cardioprotective effects of ischemic postconditioning in patients treated with primary percutaneous coronary intervention, evaluated by magnetic resonance Circ Cardiovasc Interv 3 1 2010 34 41
36. H. Thibault, C. Piot, and P. Staat Long-term benefit of postconditioning Circulation 117 8 2008 1037 1044
37. N. Mewton, P. Croisille, and G. Gahide Effect of cyclosporine on left ventricular remodelling after reperfused myocardial infarction J Am Coll Cardiol 55 12 2010 1200 1205
38. S. Ghaffari, B. Kazemi, and M. Toluey The effect of prethrombolytic cyclosporine-A injection on clinical outcome of acute anterior ST-elevation myocardial infarction Cardiovasc Ther 31 4 2013 e34 e39
39. D. Atar, H. Arheden, and A. Berdeaux Effect of intravenous TRO40303 as an adjunct to primary percutaneous coronary intervention for acute ST-elevation myocardial infarction: MITOCARE study results Eur Heart J 36 2 2015 112 119
40. B. Ibanez, C. Macaya, and V. Sanchez-Brunete Effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: the Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNIC) trial Circulation 128 14 2013 1495 1503
41. J. Lonborg, N. Vejlstrup, and H. Kelbaek Exenatide reduces reperfusion injury in patients with ST-segment elevation myocardial infarction Eur Heart J 33 12 2012 1491 1499